Marketing CBD and hemp products when the ad platforms say no

Your product is legal. Your ads keep dying anyway. Maybe the account survived a week before the disapprovals started, maybe it never served an impression at all, and the appeal went into a queue that answers in form letters. Meanwhile a competitor seems to run ads just fine, right up until their whole domain disappears from the platform.

If you sell CBD, hemp derivatives, or anything that shares a shelf with them, none of this is bad luck. It is the permanent weather of the niche. This guide explains why the platforms behave this way, what each channel actually allows as of mid 2026, and where growth really comes from while the paid lanes stay closed.

Why platforms reject a legal product

The 2018 Farm Bill made hemp-derived products with 0.3% THC or less federally legal, and owners reasonably assume that advertising follows legality. It does not. Ad platforms write policy for their own risk across every country and state they operate in, they enforce it with automated systems that read your landing pages, and they owe you no appeal. Policy moves slower than law, enforcement is blunter than policy, and both sit outside your control.

The corollary matters more than the rule. Anyone who promises to "get CBD ads approved" using cloaked landing pages or bait-and-switch domains is selling you a banned account on a delay, because platforms punish circumvention far more harshly than they punish the product itself. The brands that survive treat closed channels as closed and build on ground they own.

The channel map, honestly

Here is where each mainstream channel stands for hemp-derived products as of July 2026. Policies drift, which is why this guide carries an updated date and links the primary sources.

• Google Ads

  Constrained

  A narrow certified lane exists: topical hemp-derived CBD with 0.3% THC or less, sold by LegitScript-certified businesses, and only in the locations Google lists (currently California, Colorado, and Puerto Rico). Ingestibles, gummies, and vapes stay out entirely. If your catalog is topical and those markets matter to you, certification is worth pricing; for everyone else this lane is a footnote.

• Meta ads (Facebook and Instagram)

  Constrained

  LegitScript certification plus written authorization from Meta, US targeting only, audiences 18 and over, and the heaviest restrictions land on anything ingestible or inhalable. Organic pages live under looser rules, so treat them as owned media with reach you rent rather than an ads channel.

• Amazon

  Closed

  Amazon bans CBD outright, whatever the Farm Bill says. Listings that slip through get removed when detected, without warning. Building a business inside someone else's policy gap is paying rent on a collapsing building.

• Search (SEO)

  Open

  Nobody cards an organic listing. Rankings cannot be disapproved for what you sell, they compound instead of resetting when a budget pauses, and the niche's thin honest content makes them winnable. This is where the acquisition load lands, and it is why our cannabis-adjacent retainers lean so hard on search.

• Email and SMS

  Open, with rules

  Email is the workhorse: consented lists, retention automations, and no platform gatekeeper between you and the inbox. SMS is harsher, because US carriers filter cannabis-adjacent messaging aggressively. Build email-first and treat SMS as a bonus wherever it survives.

• Creators, affiliates, and press

  Open

  Slower to compound and harder to attribute, but unblocked, and disclosure rules apply the same as everywhere else. In a niche where paid reach is scarce, a genuine review carries unusual weight.

Where growth actually comes from

Strip away the closed lanes and the playbook stops being mysterious. Acquisition runs on search: category pages built around how people actually shop, content that answers real questions instead of chasing keywords, and the technical work that lets a store rank. Retention runs on email: welcome, abandoned cart, browse abandonment, winback, the boring automations that quietly become a third of revenue. Conversion runs on the store itself, which has to work harder than a normal store because every visitor was expensive to earn.

None of that is a secret. The brands that grow are the ones that execute that list for eight straight quarters while the weather keeps changing around them.

The parts everyone underestimates

Payments. Processors drop hemp merchants with little warning, and every drop costs a weekend of sales if the checkout was built assuming permanence. Build the store so a processor swap is a configuration change: keep your customer and order data in systems you own, and know your fallback before you need it.

Age gates. Compliance wants a gate; SEO and conversion want no friction. A gate done wrong blocks Google's crawler or bleeds your checkout. Done right, it satisfies the requirement without hiding the site from search engines or strangling the funnel. This is a solved problem, but it has to be solved on purpose.

Claims language. The fastest way to lose everything is a disease claim. Regulators read product pages, and "helps with anxiety" phrased the wrong way becomes a warning letter that follows the brand around. Write like a grown-up: what is in the product, how it is made, what the certificate of analysis shows, and nothing that promises treatment.

If you hire help for this niche

Ask three questions. Has the shop taken a store through a processor loss, and what happened next? Can they show work from this niche, even anonymized? And what do they promise about ads? The last one is the tell, because anyone guaranteeing paid reach for an ingestible CBD catalog is describing a policy violation with confidence.

For everything else about judging a marketing retainer, niche or otherwise, we keep a separate checklist: how to tell if your marketing agency is actually working.